Common allergy drug could rebuild damaged nerves in MS patients
NCT ID NCT05359653
Summary
This study is testing whether clemastine fumarate, an over-the-counter allergy medication, can repair the protective coating (myelin) around nerves that is damaged in multiple sclerosis (MS). Researchers will enroll 74 adults with relapsing-remitting MS and use specialized MRI scans to see if the drug helps regrow myelin in the brain over six months. The goal is to find a treatment that directly fixes the nerve damage causing MS disability, rather than just suppressing the immune system.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS, PRIMARY PROGRESSIVE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sandler Neurosciences Building, Neurological Clinical Research Unit
RECRUITINGSan Francisco, California, 94107, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.